Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • RheumView
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Dashboard
    • Member Directory
    • Peer Mentor Forum
    • Helpful Links
    • Become A Member
    • Renew Membership
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • RheumView
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Dashboard
    • Member Directory
    • Peer Mentor Forum
    • Helpful Links
    • Become A Member
    • Renew Membership
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

MoH Announcement:Transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles Immunization Program (For Patients 65-70 Years of Age)

Sandy Kennedy • Edition: Fall 2020

The MoH recently announced a transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles (Herpes Zoster) Immunization Program. Note, this is for patients between 65-70 years of age. Here is more information: OPDP SHINGRIX funded Oct 2020

Other Articles in the Fall 2020 Newsletter

  • President's Message
  • OMA Section on Rheumatology Report
  • Announcing the Retirement of Denis Morrice, ORA Executive Director
  • Government Affairs
  • News From Ottawa: Recent Practice Announcements
  • 2021 Membership Renewals Now Open!
  • Northern Ontario Committee
  • Communications Update
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • Biosimilar Fact Sheet
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • Become A Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy